HIMSS strongly advocated for the inclusion of $50 million in new funding, and looks forward to continuing the work with our campaign partners and the CDC to modernize the public health surveillance enterprise through upgrading IT systems and recruiting and retaining skilled data scientists.
Out of more than 130 submissions and five finalists, Thrive was chosen for its proposal to evaluate the health-economic impact of earlier multi-cancer detection, and better identify and predict populations that will most likely benefit from this approach.
HIMSS and the Personal Connected Health Alliance (PCHAlliance) provided written comments to the Food and Drug Administration’s (FDA’s) Clinical Decision Support Software; Draft Guidance for Industry and Food and Drug Administration Staff.
HIMSS and PCHAlliance Comment on Updates to the Anti-Kickback and Physician Self-Referral Regulations
HIMSS and the Personal Connected Health Alliance provided written comments on two separate proposed regulations.